When the test lies: Fatal cryptococcosis and the prozone effect in advanced HIV infection.

Diagn Microbiol Infect DisJun 13, 2026 (epub)

Mylene Costa, Patrícia Rodrigues, Beatriz Araújo et al.

✦ AI-curated · Sources linked

Case in brief

A 37-year-old man with advanced HIV infection presented with altered mental status. Initial cryptococcal antigen (CrAg) tests on serum and cerebrospinal fluid (CSF) were negative. However, India ink staining revealed encapsulated yeasts, leading to positive CrAg results upon serial dilution. Cultures confirmed disseminated cryptococcosis. Despite treatment, the patient succumbed to neurological deterioration.

What made this case unusual

The case highlights the prozone effect, where high antigen levels lead to false-negative CrAg results, complicating diagnosis.

Diagnostic / clinical pearl

Clinicians should be aware of the prozone effect in cryptococcal antigen testing, especially in patients with advanced HIV, and consider retesting with serial dilutions when initial results are negative.

Why it matters

This case emphasizes the importance of integrating clinical findings with laboratory results to avoid misdiagnosis in life-threatening infections.

Source

Published in Diagn Microbiol Infect Dis. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.